Device Trial Radar · NCT04437082
Performance Evaluation of OCT and OCT Angiography-based Ocular Measurements (Optical Coherence Tomography)
Last checked: Nov 20, 2026Latest source record: Sep 20, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
143
Actual
Start
Jan 15, 2021
Primary completion
Apr 30, 2021
Study completion Apr 30, 2021
Sponsor
- Lead sponsor
- OptovueNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 18, 2020
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess performance of measurements of anatomical and vascular structures of the eye based on OCT and OCTA scans in normal subjects and eyes with pathology.
Conditions
- Normal Eyes and Ocular Pathology
Interventions
optical coherence tomographyDevice
imaging structural and vascular features of the eye
Primary outcomes
What the sponsor says the trial is designed to measure.
- Standard DeviationTime frame: Day 1
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Oklahoma College of Optometry, Northeastern State University
Tahlequah, Oklahoma
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.